Public signalCompany raiseAuto-indexed · Unverified
Cambrian BioPharma Inc raised $23.0M
Cambrian BioPharma Inc· NEW YORK, US· Pharmaceuticals· Filed Jan 13, 2025
Cambrian BioPharma Inc reported raising capital. Based in NEW YORK, NEW YORK, US. First sale reported 2023-06-02. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$23.0M
Confidence90%
Raised
$23.0M
Investors
30
Jurisdiction
DELAWARE
On the record
- Location
- NEW YORK, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $23.0M
- Target amount
- $37.6M
- Filing date
- Jan 13, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 30
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $37.6M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 23,022,065 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 13, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyPharmaceuticals$10M – $100MCompany Raise
Are you associated with Cambrian BioPharma Inc?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record